ClinicalTrials.Veeva

Menu

The Role of Dry Needling in Hallux Valgus

I

Istanbul Training and Research Hospital

Status

Completed

Conditions

Hallux Valgus
Myofascial Pain Syndrome

Treatments

Other: Dry needling+Toe spread out
Other: Toe spread out

Study type

Interventional

Funder types

Other

Identifiers

NCT06023823
07/04/2023 2011-KAEK-50;88;

Details and patient eligibility

About

Forty Hallux valgus patients between the ages of 25-65 years, who are admitted to the Physical Medicine and Rehabilitation clinic with the complaint of 1st Metatarsophalangeal (MTF) pain and who meet the inclusion and exclusion criteria will be included. Hallux valgus (HV) angles will be measured by dorsoplantar radiography before the patients start the study. The HV angle was measured as the angle between the bisection line of the first metatarsal bone and the first proximal phalanx. Demographic data (age, gender, body mass index) will be recorded at the beginning of the study. Then, the initial Foot Functional Index (FFI) and Visual Analog Scale (VAS) scales were completed. The 1st MTF joint angle was also measured with a goniometer and recorded before starting the study. The patients were divided into two groups. The first group will be given 3 sessions of dry needling with Seirin branded 0.6*50 mm acupuncture needles for trigger point in the abductor hallucis muscle and toe-spread-out exercise. The second group will receive only toe-spread-out exercises. After starting the treatment, FFI and VAS scores and 1st MTF angles will be measured and recorded weekly with a goniometer. At the end of the 3-week treatment, the FFI and VAS scores of the participants will be re-evaluated after 1 week and 1 month, and the participants will be re-evaluated with a goniometer. The hallux valgus angle will be re-evaluated with X-ray 4 weeks after the end of the treatment.

Enrollment

31 patients

Sex

All

Ages

25 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • 25-65 years old with pain for more than 4 weeks
  • Hallux valgus angle between 16-40 degrees
  • Activity VAS value above 4

Exclusion criteria

  • Patients diagnosed with rheumatologic diseases
  • Those diagnosed with Diabetes Mellitus (DM), those with chronic liver and kidney failure
  • Those who received anti-inflammatory-analgesic treatment in the last 1 week
  • Diagnosed with inflammatory rheumatic disease
  • Those with a history of foot surgery
  • Those with mid or hindfoot deformity
  • Those with 1st MTF joint problems other than hallux valgus
  • Those with a history of orthotic use
  • Previous history of central or peripheral nerve damage, lower extremity neuropathy
  • Those diagnosed with Diabetes Mellitus
  • Those with cognitive impairment
  • Unassisted mobilization

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

31 participants in 2 patient groups

Toe spread out treatment
Active Comparator group
Treatment:
Other: Toe spread out
Other: Dry needling+Toe spread out
Dry needling
Active Comparator group
Treatment:
Other: Dry needling+Toe spread out

Trial contacts and locations

1

Loading...

Central trial contact

Burak Tayyip Dede; Burak Tayyip Dede

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems